Yes, it is crazy to see STAR at under $2.00. Looking around the market, and seeing the prices of other stocks that are running on hype, deserved or not, just amazes me. This stock should be running at at least $15.00 to $20.00 dollars at the moment, if not more. The potential here is beyond belief, and I know because I am a user. Slammers say that revenue is all important, but I see many companies with no revenue that have evaluations ten times or more than STAR. I will stick with STAR until the world wakes up, or gets hit in the face. Thanks to all the posters that come up with great data. Hopefully, the investment community will wake up to the fact that Anatabine in current form, and in an isolated isomer form for drugs, is one of the biggest events in decades. $2.00 a share? What a joke!